Skip to main content
. Author manuscript; available in PMC: 2025 Nov 12.
Published before final editing as: Eur Heart J Cardiovasc Imaging. 2025 Sep 23:jeaf279. doi: 10.1093/ehjci/jeaf279

Table 1.

Participant demographics stratified by age and absence or presence of AVC

AVC = 0 (n=5,899) p-value AVC >0 (n=911) p-value
Age <65 (n=3,645) Age ≥65 (n=2,257) Age <65 (n=189) Age ≥65 (n=722)
Age, years 54.3 (5.7) 71.4 (4.9) <0.001 58.4 (4.3) 73.7 (5.3)
Women 54.3% 55.8% 0.261 32.8% 41.8% 0.024
Race
  White 37.3% 37.6% 0.783 42.3% 46.1% 0.783
  Black 27.7& 28.9% 0.287 24.4% 25.7% 0.287
  Chinese 23.1% 20.2% 0.008 28.0% 20.3% 0.008
  Hispanic 12.0% 13.3% 0.144 5.3% 7.9% 0.144
Systolic blood pressure, mm Hg 120.4 (18.7) 133.1 (22.3) <0.001 130.1 (20.7) 136.3 (22.3) <0.001
Diastolic blood pressure, mm Hg 72.4 (10.2) 71.0 (10.4) <0.001 75.4 (10.4) 71.4 (9.8) <0.001
Hypertension 46.7% 73% <0.001 68.8% 80.9% <0.001
Antihypertensive medication 23.4% 47.4% <0.001 45.5% 58% <0.001
LDL-C, mg/dL 118.0 (31.6) 115.3 (29.9) 0.001 129.2 (39.2) 115.9 (32.5) <0.001
HDL-C, mg/dL 50.3 (14.6) 52.8 (15.2) <0.001 47.0 (13.2) 49.5 (14.4) 0.036
Triglycerides, mg/dL* 112 (77, 164) 107 (76,155) 0.007 133 (92,186) 118 (82, 166) 0.017
Lipoprotein(a), mg/dL* 16.5 (7, 39) 17.5 (8,38) 0.296 25.4 (9, 67) 19 (8, 52) 0.027
Hyperlipidemia 43.5% 47.8% <0.001 63.0% 53.6% 0.001
Lipid-lowering medication 11.0% 20.7% 0.001 22.0% 27.2% <0.001
Glucose, mg/dL 95.3 (30.8) 98.6 (25.9) <0.001 103.5 (40.4) 102.5 (35.7) 0.739
Diabetes 9.8% 14.1% <0.001 21.2% 19.5% <0.001
Body mass index, kg/m2 28.7 (5.7) 27.7 (5.2) <0.001 30.0 (5.4) 28.1 (4.7) <0.001
Current smoking 17.0% 7.6% <0.001 20.1% 8.0% <0.001
10-year ASCVD risk score, % 6.0 (6.1) 21.1 (12.9) <0.001 12.0 (8.9) 28.0 (15.1) <0.001
Coronary artery calcium * 0 (0, 9.6) 25 (0, 173) <0.001 33 (0, 223) 155 (21, 536) <0.001
Aortic valve calcium* 0 0 n/a 34.1 (13, 1,113) 69.0 (23, 2,453) <0.001
*

Median and interquartile range